Simon Walsh

Intravascular ultrasound to guide left main stem intervention: a NOBLE trial substudy

Ladwiniec A, Walsh S, Holm N, Hanratty C, Mäkikallio T, Kellerth T, Hildick-Smith D, Mogensen L, Hartikainen J, Menown I, Erglis A, Eriksen E, Spence M, Thuesen L, Christiansen E

June 25, 2020 | 10.4244/EIJ-D-19-01003

Intravascular lithotripsy for lesion preparation in patients with calcific distal left main disease

Cosgrove C, Wilson S, Bogle R, Hanratty C, Williams R, Walsh S, McEntegart M, Spratt J

May 20, 2020 | 10.4244/EIJ-D-19-01052

Incidence of “Shocktopics” and asynchronous cardiac pacing in patients undergoing coronary intravascular lithotripsy

Wilson S, Spratt J, Hill J, Spence M, Cosgrove C, Jones J, Strange J, Halperin H, Walsh S, Hanratty C

March 20, 2020 | 10.4244/EIJ-D-19-00484

Coronary interventions

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial

Serruys PW, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang C, Spitzer E, Walsh S, Adlam D, Hildick-Smith D, Édes I, van de Harst P, Krackhardt F, Tijssen J, Rademaker-Havinga T, Garg S, Steg P, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt F

December 20, 2019 | 10.4244/EIJ-D-19-00202

Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial

Lipiecki J, Brunel P, Morice M, Roguelov C, Walsh S, Richardt G, Eerdmans P, Zambahari R, Berland J, Copt S, Stoll H, Urban P

July 20, 2018 | 10.4244/EIJ-D-18-00293

Culotte stenting for coronary bifurcation lesions with 2nd and 3rd generation everolimus-eluting stents: the CELTIC Bifurcation Study

Walsh S, Hanratty C, Watkins S, Oldroyd K, Mulvihill N, Hensey M, Chase A, Smith D, Cruden N, Spratt J, Mylotte D, Johnson T, Hill J, Hussein H, Bogaerts K, Morice M, Foley DP

June 14, 2018 | 10.4244/EIJ-D-18-00346

Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Meredith I, Verheye S, Dubois C, Dens J, Farah B, Carrié D, Walsh S, Oldroyd K, Varenne O, El-Jack S, Moreno R, Christen T, Allocco D

April 20, 2018 | 10.4244/EIJ-D-17-00529

Coronary interventions

Effects of successful percutaneous coronary intervention of chronic total occlusions on myocardial perfusion and left ventricular function

Stuijfzand W, Biesbroek P, Raijmakers P, Driessen R, Schumacher S, van Diemen P, van den Berg J, Nijveldt R, Lammertsma A, Walsh S, Hanratty C, Spratt J, van Rossum A, Nap A, van Royen N, Knaapen P

June 20, 2017 | 10.4244/EIJ-D-16-01014

Coronary interventions

Optimal approach to percutaneous intervention for CTO in 2017: a hybrid strategy is now the preferred choice

Walsh S, Hanratty C, Spratt J

February 3, 2017 | 10.4244/EIJV12I15A294

Coronary interventions

The first clinical experience with a novel “locking” microcatheter in chronic coronary total occlusions

Wilson S, Maeramans J, Walsh S, Hanratty C, Meyer-Gessner M, Dens J, Christiansen E, Bufe A, Spratt J

February 3, 2017 | 10.4244/EIJ-D-16-00272

Coronary interventions

The collateral circulation of coronary chronic total occlusions

McEntegart M, Badar A, Ahmad F, Shaukat A, MacPherson M, Irving J, Strange J, Bagnall A, Hanratty C, Walsh S, Werner G, Spratt J

April 8, 2016 | 10.4244/EIJV11I14A310

Coronary interventions

Percutaneous coronary intervention for chronic total occlusions: time to move from the annex to mainstream?

Walsh S, Hanratty C

January 20, 2016 | 10.4244/EIJV11I9A200

A novel approach to the management of occlusive in-stent restenosis (ISR)

Wilson W, Walsh S, Hanratty C, Strange J, Hill J, Sapontis J, Spratt J

March 20, 2014 | 10.4244/EIJV9I11A218

Longitudinal compression: a “new” complication with modern coronary stent platforms – time to think beyond deliverability?

Hanratty C, Walsh S

November 30, 2011 | 10.4244/EIJV7I7A135

Simon Walsh

Latest news